Literature DB >> 9608016

Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins.

E Kompanowska-Jezierska1, C Emmeluth, L Grove, P Christensen, J Sadowski, P Bie.   

Abstract

Renal effects of physiological amounts of vasopressin were studied in conscious dogs during servocontrolled overhydration (2% body wt). During infusion of vasopressin (50 pg . min-1 . kg body wt-1), plasma vasopressin concentration increased to 2.30 +/- 0.20 pg/ml compared with 0.12 +/- 0.03 pg/ml during control (water diuresis). With vasopressin infusion, urine flow was significantly lower (0.30 +/- 0.10 ml/min) and sodium excretion (UNaV) was significantly higher (58.0 +/- 15.8 micromol/min) than without vasopressin (4.6 +/- 0.4 ml/min and 14.4 +/- 4.1 micromol/min, respectively). Deamino-[Cys1,D-Arg8]vasopressin, a V2 receptor agonist (4 pg . min-1 . kg-1), mimicked the antidiuretic response (0.20 +/- 0.03 ml/min) without changing UNaV (9.7 +/- 4.4 micromol/min). Indomethacin given during arginine vasopressin (AVP) infusion suppressed prostaglandin E2 excretion, intensified the antidiuresis (0.10 +/- 0.02 ml/min), and abolished the natriuresis (13.4 +/- 3.7 micromol/min). During AVP infusion, UNaV was highly correlated (r = 0.85) with prostaglandin E2 excretion. Blood pressure, glomerular filtration rate, plasma atrial natriuretic peptide concentration, and the rate of proximal tubule reabsorption (derived from lithium clearance) were similar in all series. The data indicate that, in the dog, physiological amounts of vasopressin can induce natriuresis, probably through activation of non-V2 receptors and the intrarenal synthesis of prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9608016     DOI: 10.1152/ajpregu.1998.274.6.R1619

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus.

Authors:  Vincenzo Zanardo; Stefania Vedovato; Paola Lago; Daniele Trevisanuto; Flaviano Favaro; Diego Faggian; Mario Plebani
Journal:  Pediatr Nephrol       Date:  2005-08-17       Impact factor: 3.714

2.  Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.

Authors:  Anne Blanchard; Michael Frank; Grégoire Wuerzner; Severine Peyrard; Lise Bankir; Xavier Jeunemaitre; Michel Azizi
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-13       Impact factor: 8.237

3.  Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.

Authors:  Julie Perucca; Daniel G Bichet; Pascale Bardoux; Nadine Bouby; Lise Bankir
Journal:  J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 10.121

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.